AU3596197A - Highly synergistic neutralization of hiv through combinations of monoclonal and polyclonal antibodies - Google Patents

Highly synergistic neutralization of hiv through combinations of monoclonal and polyclonal antibodies

Info

Publication number
AU3596197A
AU3596197A AU35961/97A AU3596197A AU3596197A AU 3596197 A AU3596197 A AU 3596197A AU 35961/97 A AU35961/97 A AU 35961/97A AU 3596197 A AU3596197 A AU 3596197A AU 3596197 A AU3596197 A AU 3596197A
Authority
AU
Australia
Prior art keywords
hiv
monoclonal
combinations
polyclonal antibodies
highly synergistic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35961/97A
Inventor
Christine V. Sapan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nabi Inc
Original Assignee
Nabi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabi Inc filed Critical Nabi Inc
Publication of AU3596197A publication Critical patent/AU3596197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU35961/97A 1996-07-10 1997-07-08 Highly synergistic neutralization of hiv through combinations of monoclonal and polyclonal antibodies Abandoned AU3596197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67916096A 1996-07-10 1996-07-10
US08679160 1996-07-10
PCT/US1997/011824 WO1998001476A1 (en) 1996-07-10 1997-07-08 Highly synergistic neutralization of hiv through combinations of monoclonal and polyclonal antibodies

Publications (1)

Publication Number Publication Date
AU3596197A true AU3596197A (en) 1998-02-02

Family

ID=24725808

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35961/97A Abandoned AU3596197A (en) 1996-07-10 1997-07-08 Highly synergistic neutralization of hiv through combinations of monoclonal and polyclonal antibodies

Country Status (2)

Country Link
AU (1) AU3596197A (en)
WO (1) WO1998001476A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007084692A2 (en) * 2006-01-20 2007-07-26 Welson Pharmaceuticals, Inc. Immunoconjugates for treatment of infectious diseases
US8821879B2 (en) 2009-09-04 2014-09-02 Xoma Technology Ltd. Anti-botulism antibody coformulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0379516B1 (en) * 1987-08-11 1993-10-06 The Regents Of The University Of Minnesota Hyper-immune globulin against hiv
AU6663990A (en) * 1989-11-13 1991-05-16 Green Cross Corporation, The Chimeric mouse-human antibodies with specificity to hiv antigens
WO1993008216A1 (en) * 1991-10-15 1993-04-29 New York University Human monoclonal antibodies to the cd4-binding domain of hiv, uses thereof and synergistic neutralization of hiv

Also Published As

Publication number Publication date
WO1998001476A1 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
AU735411C (en) Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
PL314908A1 (en) Humanised antibodies and their application
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU1209495A (en) Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
EP1043335A4 (en) Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
IL128406A0 (en) Monoclonal antibodies
AU7863794A (en) Antihuman tyrosinase monoclonal antibody
AU5365296A (en) Human monoclonal antibody against lung carcinoma
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
AU2097592A (en) Fibrinogen-specific monoclonal antibody and uses thereof
AU6750594A (en) Receptors of interleukin-12 and antibodies
AU7160691A (en) Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes
PL325457A1 (en) Humanised antibodies effective against human fas
PL320610A1 (en) Fragments of monoclonal antibodies of immunosuppressive activity
AU2596397A (en) Monoclonal antibody that detects apoptotic antigen
AU7113696A (en) Detection and quantitation of 8-oh-adenine using monoclonal antibodies
AU7014294A (en) Human monoclonal antibodies and processes and materials for making such antibodies
AU7690496A (en) Monoclonal antiidiotypic antibodies (AB2) and their uses
AU3596197A (en) Highly synergistic neutralization of hiv through combinations of monoclonal and polyclonal antibodies
AU657504B2 (en) Antibody against human plasmin-alpha2-plasmin inhibitor complex, hybridoma and immunoassay
AU6969096A (en) Monoclonal lymphocytes and methods of use
AU2040995A (en) Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase
GB9519460D0 (en) Polyclonal antibodies and their use
ZA9610336B (en) Anti-cd6 monoclonal antibodies and their uses
AU4466596A (en) Combined treatment of iron depletion and igg antibody